Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Pfizer Recalls Advil Liqui-Gel Bottles Because of Odor Concern
Pfizer Inc. has recently issued a voluntary recall of several lots of Advil Liqui-Gels due to the potential for the product to have a strong odor resulting from the manufacturing process. The recall, which involved 40 count, 40+20 count and 240 count bottles, was at the level of retail-distribution centers only; the recall was not at the consumer level. The lot number involved include: F48768, F71099, F74724, 42281, 42284, 42285, 42288, 42291, 1355CB, 1712FR, 1412RR, 1612RR, 2010KA, 1362KA, 1361KA, 1712AR, 1612AR, 1112CRA, 1812AR, 1212CR, 1112CR, 2005HA, and 2053DA. A company spokesperson has stated that Pfizer has been able to isolate the issue and has taken corrective action. Unaffected lots of Advil Liqui-Gels remain available in stores, according to Pfizer. At this time, no safety or adverse-event concerns have been associated with the recall For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm304512.htm?source=govdelivery and http://online.wsj.com/article/BT-CO-20120518-709216.html
Learn More

Sunovion Pharmaceuticals Recalls a Single Lot of Omnaris (ciclesonide) Nasal Spray 50 mcg
Sunovion Pharmaceuticals has recalled a single lot of Omnaris (ciclesonide) Nasal Spray 50 mcg. Lot number 138122 has been recalled because this lot did not meet the manufacturer’s preservative and purity requirements. Omnaris contains the active ingredient ciclesonide and is commonly used in the treatment of allergies. This recall alert only applies to the single lot of Omnaris (ciclesonide) Nasal Spray 50 mcg. No other ciclesonide products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm304512.htm
Learn More

Date Published Title Drug Source
2012-05-21 Pfizer Recalls Advil Liqui-Gel Bottles Because of Odor Concern Ibuprofen FDA
2012-05-21 Sunovion Pharmaceuticals Recalls a Single Lot of Omnaris (ciclesonide) Nasal Spray 50 mcg Ciclesonide Nasal FDA
2012-05-21 Warner Chilcott Company LLC Recalls Several Lots of Ovcon 50 Norethindrone with Ethinyl Estradiol FDA
2012-05-21 Lupin Pharmaceuticals Inc. Recalls Single Lots of Levonorgestrel and Ethinyl Estradiol Tablets (0.1 mg/0.02 mg) and Ethinyl Estradiol Tablets (0.01 mg) Levonorgestrel with Ethinylestradiol FDA
2012-05-22 FDA's New Pediatric Prescribing Information Database is a Resource for Parents and Caregivers FDA
2012-05-23 McNeil Consumer Healthcare Recalls Imodium Manufacturer
2012-05-24 Franck’s Pharmacy Recalls All Sterile Human and Veterinary Compounded Prescriptions Distributed Between November 21, 2011 to May 21, 2012 FDA
2012-05-30 FDA Warns Consumers About Counterfeit Version of Teva’s Adderall Amphetamine Salts FDA
2012-05-31 FDA Warns: Benzocaine and Babies Are Not a Good Mix Benzocaine FDA
2012-05-31 Merck Inc. Recalls Several Lots of Celestone brand of Betamethasone Oral Solution, 0.6 mg/ 5 mL Betamethasone FDA
2012-06-07 Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw Levonorgestrel with Ethinylestradiol FDA
2012-06-26 FDA Warns Cefepime Needs Dosage Reduced in Patients with Poor Kidney Function Cefepime FDA
2012-06-29 FDA Consumer Update: How Long Should You Take Osteoporosis Drugs? Ibandronate Sodium FDA
2012-07-05 Physicians Total Care, Inc Recalls Several Lots of Morphine Sulfate Extended Release and Immediate Release tablet, 30 mg Morphine FDA
2012-07-05 Teva Pharmaceuticals Recalls Several Lots of Jolessa 0.15 mg/0.03 mg Levonorgestrel with Ethinylestradiol FDA
2012-07-05 Physicians Total Care Recalls Several Lots of Lipitor (Atorvastatin calcium) 40 mg Atorvastatin FDA
2012-07-10 FDA Approves Safety Program to Reduce Risk of Opioid Pain Relievers Methadone FDA
2012-07-10 FDA Approves Safety Program to Reduce Risk of Opioid Pain Relievers Oxymorphone FDA
2012-07-19 TEVA Phamaceuticals Recalls Single Lot of Metoprolol Tartrate Tablets 50 mg Metoprolol FDA
2012-07-19 Ranbaxy Recalls Single Lot of Balnetar Therapeutic Tar Bath, Coal Tar 2.5% FDA